nodes	percent_of_prediction	percent_of_DWPC	metapath
Orciprenaline—Hypokalaemia—Vismodegib—skin cancer	0.0286	0.0286	CcSEcCtD
Orciprenaline—Dysgeusia—Vismodegib—skin cancer	0.0185	0.0185	CcSEcCtD
Orciprenaline—Muscle spasms—Vismodegib—skin cancer	0.0182	0.0182	CcSEcCtD
Orciprenaline—Myalgia—Vismodegib—skin cancer	0.0161	0.0161	CcSEcCtD
Orciprenaline—Influenza—Imiquimod—skin cancer	0.0143	0.0143	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Vismodegib—skin cancer	0.0141	0.0141	CcSEcCtD
Orciprenaline—Sweating increased—Imiquimod—skin cancer	0.0139	0.0139	CcSEcCtD
Orciprenaline—Fatigue—Vismodegib—skin cancer	0.0133	0.0133	CcSEcCtD
Orciprenaline—Pain—Vismodegib—skin cancer	0.0132	0.0132	CcSEcCtD
Orciprenaline—Chills—Vemurafenib—skin cancer	0.012	0.012	CcSEcCtD
Orciprenaline—Dysgeusia—Vemurafenib—skin cancer	0.0114	0.0114	CcSEcCtD
Orciprenaline—Asthenia—Vismodegib—skin cancer	0.0111	0.0111	CcSEcCtD
Orciprenaline—Pruritus—Vismodegib—skin cancer	0.0109	0.0109	CcSEcCtD
Orciprenaline—Diarrhoea—Vismodegib—skin cancer	0.0106	0.0106	CcSEcCtD
Orciprenaline—Chills—Imiquimod—skin cancer	0.0103	0.0103	CcSEcCtD
Orciprenaline—Arrhythmia—Imiquimod—skin cancer	0.0102	0.0102	CcSEcCtD
Orciprenaline—Cough—Vemurafenib—skin cancer	0.0102	0.0102	CcSEcCtD
Orciprenaline—Bronchospasm—Bleomycin—skin cancer	0.00999	0.00999	CcSEcCtD
Orciprenaline—Myalgia—Vemurafenib—skin cancer	0.00994	0.00994	CcSEcCtD
Orciprenaline—Vomiting—Vismodegib—skin cancer	0.00981	0.00981	CcSEcCtD
Orciprenaline—Anaphylactic shock—Vemurafenib—skin cancer	0.00953	0.00953	CcSEcCtD
Orciprenaline—Nausea—Vismodegib—skin cancer	0.00916	0.00916	CcSEcCtD
Orciprenaline—Hypokalaemia—Temozolomide—skin cancer	0.00902	0.00902	CcSEcCtD
Orciprenaline—Syncope—Imiquimod—skin cancer	0.00893	0.00893	CcSEcCtD
Orciprenaline—Palpitations—Imiquimod—skin cancer	0.0088	0.0088	CcSEcCtD
Orciprenaline—Loss of consciousness—Imiquimod—skin cancer	0.00875	0.00875	CcSEcCtD
Orciprenaline—Cough—Imiquimod—skin cancer	0.00869	0.00869	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00868	0.00868	CcSEcCtD
Orciprenaline—Hypertension—Imiquimod—skin cancer	0.0086	0.0086	CcSEcCtD
Orciprenaline—Myalgia—Imiquimod—skin cancer	0.00848	0.00848	CcSEcCtD
Orciprenaline—Chest pain—Imiquimod—skin cancer	0.00848	0.00848	CcSEcCtD
Orciprenaline—Sweating increased—Temozolomide—skin cancer	0.00834	0.00834	CcSEcCtD
Orciprenaline—Dry mouth—Imiquimod—skin cancer	0.00829	0.00829	CcSEcCtD
Orciprenaline—Fatigue—Vemurafenib—skin cancer	0.00822	0.00822	CcSEcCtD
Orciprenaline—Oedema—Imiquimod—skin cancer	0.00813	0.00813	CcSEcCtD
Orciprenaline—Shock—Imiquimod—skin cancer	0.008	0.008	CcSEcCtD
Orciprenaline—Tachycardia—Imiquimod—skin cancer	0.00793	0.00793	CcSEcCtD
Orciprenaline—Hyperhidrosis—Imiquimod—skin cancer	0.00786	0.00786	CcSEcCtD
Orciprenaline—Body temperature increased—Vemurafenib—skin cancer	0.00753	0.00753	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Imiquimod—skin cancer	0.0074	0.0074	CcSEcCtD
Orciprenaline—Insomnia—Imiquimod—skin cancer	0.00735	0.00735	CcSEcCtD
Orciprenaline—Chills—Bleomycin—skin cancer	0.00729	0.00729	CcSEcCtD
Orciprenaline—Somnolence—Imiquimod—skin cancer	0.00723	0.00723	CcSEcCtD
Orciprenaline—Hypersensitivity—Vemurafenib—skin cancer	0.00702	0.00702	CcSEcCtD
Orciprenaline—Fatigue—Imiquimod—skin cancer	0.00701	0.00701	CcSEcCtD
Orciprenaline—Pain—Imiquimod—skin cancer	0.00695	0.00695	CcSEcCtD
Orciprenaline—Asthenia—Vemurafenib—skin cancer	0.00684	0.00684	CcSEcCtD
Orciprenaline—Chills—Dactinomycin—skin cancer	0.0068	0.0068	CcSEcCtD
Orciprenaline—Pruritus—Vemurafenib—skin cancer	0.00674	0.00674	CcSEcCtD
Orciprenaline—Diarrhoea—Vemurafenib—skin cancer	0.00652	0.00652	CcSEcCtD
Orciprenaline—Urticaria—Imiquimod—skin cancer	0.00646	0.00646	CcSEcCtD
Orciprenaline—Body temperature increased—Imiquimod—skin cancer	0.00642	0.00642	CcSEcCtD
Orciprenaline—Dizziness—Vemurafenib—skin cancer	0.0063	0.0063	CcSEcCtD
Orciprenaline—Cough—Bleomycin—skin cancer	0.00617	0.00617	CcSEcCtD
Orciprenaline—Chills—Temozolomide—skin cancer	0.00615	0.00615	CcSEcCtD
Orciprenaline—Vomiting—Vemurafenib—skin cancer	0.00606	0.00606	CcSEcCtD
Orciprenaline—Chest pain—Bleomycin—skin cancer	0.00602	0.00602	CcSEcCtD
Orciprenaline—Myalgia—Bleomycin—skin cancer	0.00602	0.00602	CcSEcCtD
Orciprenaline—Hypersensitivity—Imiquimod—skin cancer	0.00599	0.00599	CcSEcCtD
Orciprenaline—Headache—Vemurafenib—skin cancer	0.00597	0.00597	CcSEcCtD
Orciprenaline—Cramp muscle—Docetaxel—skin cancer	0.00593	0.00593	CcSEcCtD
Orciprenaline—Dysgeusia—Temozolomide—skin cancer	0.00584	0.00584	CcSEcCtD
Orciprenaline—Asthenia—Imiquimod—skin cancer	0.00583	0.00583	CcSEcCtD
Orciprenaline—Oedema—Bleomycin—skin cancer	0.00577	0.00577	CcSEcCtD
Orciprenaline—Anaphylactic shock—Bleomycin—skin cancer	0.00577	0.00577	CcSEcCtD
Orciprenaline—Pruritus—Imiquimod—skin cancer	0.00575	0.00575	CcSEcCtD
Orciprenaline—Nausea—Vemurafenib—skin cancer	0.00566	0.00566	CcSEcCtD
Orciprenaline—Arrhythmia—Fluorouracil—skin cancer	0.00564	0.00564	CcSEcCtD
Orciprenaline—Vision blurred—Temozolomide—skin cancer	0.00562	0.00562	CcSEcCtD
Orciprenaline—Myalgia—Dactinomycin—skin cancer	0.00562	0.00562	CcSEcCtD
Orciprenaline—Bronchospasm—Docetaxel—skin cancer	0.0056	0.0056	CcSEcCtD
Orciprenaline—Tremor—Temozolomide—skin cancer	0.00559	0.00559	CcSEcCtD
Orciprenaline—Diarrhoea—Imiquimod—skin cancer	0.00556	0.00556	CcSEcCtD
Orciprenaline—Oedema—Dactinomycin—skin cancer	0.00538	0.00538	CcSEcCtD
Orciprenaline—Dizziness—Imiquimod—skin cancer	0.00537	0.00537	CcSEcCtD
Orciprenaline—Palpitations—Temozolomide—skin cancer	0.00527	0.00527	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00526	0.00526	CcSEcCtD
Orciprenaline—Cough—Temozolomide—skin cancer	0.00521	0.00521	CcSEcCtD
Orciprenaline—Vision blurred—Fluorouracil—skin cancer	0.00518	0.00518	CcSEcCtD
Orciprenaline—Vomiting—Imiquimod—skin cancer	0.00517	0.00517	CcSEcCtD
Orciprenaline—Hypertension—Temozolomide—skin cancer	0.00515	0.00515	CcSEcCtD
Orciprenaline—Headache—Imiquimod—skin cancer	0.00509	0.00509	CcSEcCtD
Orciprenaline—Myalgia—Temozolomide—skin cancer	0.00508	0.00508	CcSEcCtD
Orciprenaline—Dry mouth—Temozolomide—skin cancer	0.00497	0.00497	CcSEcCtD
Orciprenaline—Pain—Bleomycin—skin cancer	0.00494	0.00494	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00491	0.00491	CcSEcCtD
Orciprenaline—Oedema—Temozolomide—skin cancer	0.00487	0.00487	CcSEcCtD
Orciprenaline—Anaphylactic shock—Temozolomide—skin cancer	0.00487	0.00487	CcSEcCtD
Orciprenaline—Nausea—Imiquimod—skin cancer	0.00483	0.00483	CcSEcCtD
Orciprenaline—Hyperhidrosis—Temozolomide—skin cancer	0.00471	0.00471	CcSEcCtD
Orciprenaline—Myalgia—Fluorouracil—skin cancer	0.00468	0.00468	CcSEcCtD
Orciprenaline—Chest pain—Fluorouracil—skin cancer	0.00468	0.00468	CcSEcCtD
Orciprenaline—Fatigue—Dactinomycin—skin cancer	0.00464	0.00464	CcSEcCtD
Orciprenaline—Pain—Dactinomycin—skin cancer	0.0046	0.0046	CcSEcCtD
Orciprenaline—Urticaria—Bleomycin—skin cancer	0.00459	0.00459	CcSEcCtD
Orciprenaline—Body temperature increased—Bleomycin—skin cancer	0.00456	0.00456	CcSEcCtD
Orciprenaline—Oedema—Fluorouracil—skin cancer	0.00449	0.00449	CcSEcCtD
Orciprenaline—Anaphylactic shock—Fluorouracil—skin cancer	0.00449	0.00449	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00444	0.00444	CcSEcCtD
Orciprenaline—Insomnia—Temozolomide—skin cancer	0.00441	0.00441	CcSEcCtD
Orciprenaline—Tachycardia—Fluorouracil—skin cancer	0.00438	0.00438	CcSEcCtD
Orciprenaline—Somnolence—Temozolomide—skin cancer	0.00433	0.00433	CcSEcCtD
Orciprenaline—Body temperature increased—Dactinomycin—skin cancer	0.00426	0.00426	CcSEcCtD
Orciprenaline—Hypersensitivity—Bleomycin—skin cancer	0.00425	0.00425	CcSEcCtD
Orciprenaline—Fatigue—Temozolomide—skin cancer	0.0042	0.0042	CcSEcCtD
Orciprenaline—Pain—Temozolomide—skin cancer	0.00416	0.00416	CcSEcCtD
Orciprenaline—Asthenia—Bleomycin—skin cancer	0.00414	0.00414	CcSEcCtD
Orciprenaline—Chills—Docetaxel—skin cancer	0.00409	0.00409	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00409	0.00409	CcSEcCtD
Orciprenaline—Pruritus—Bleomycin—skin cancer	0.00408	0.00408	CcSEcCtD
Orciprenaline—Arrhythmia—Docetaxel—skin cancer	0.00407	0.00407	CcSEcCtD
Orciprenaline—Insomnia—Fluorouracil—skin cancer	0.00406	0.00406	CcSEcCtD
Orciprenaline—Somnolence—Fluorouracil—skin cancer	0.00399	0.00399	CcSEcCtD
Orciprenaline—Hypersensitivity—Dactinomycin—skin cancer	0.00397	0.00397	CcSEcCtD
Orciprenaline—Dysgeusia—Docetaxel—skin cancer	0.00389	0.00389	CcSEcCtD
Orciprenaline—Urticaria—Temozolomide—skin cancer	0.00387	0.00387	CcSEcCtD
Orciprenaline—Asthenia—Dactinomycin—skin cancer	0.00386	0.00386	CcSEcCtD
Orciprenaline—Body temperature increased—Temozolomide—skin cancer	0.00385	0.00385	CcSEcCtD
Orciprenaline—Pain—Fluorouracil—skin cancer	0.00384	0.00384	CcSEcCtD
Orciprenaline—Muscle spasms—Docetaxel—skin cancer	0.00382	0.00382	CcSEcCtD
Orciprenaline—Diarrhoea—Dactinomycin—skin cancer	0.00368	0.00368	CcSEcCtD
Orciprenaline—Vomiting—Bleomycin—skin cancer	0.00367	0.00367	CcSEcCtD
Orciprenaline—Hypersensitivity—Temozolomide—skin cancer	0.00359	0.00359	CcSEcCtD
Orciprenaline—Urticaria—Fluorouracil—skin cancer	0.00356	0.00356	CcSEcCtD
Orciprenaline—Syncope—Docetaxel—skin cancer	0.00356	0.00356	CcSEcCtD
Orciprenaline—Body temperature increased—Fluorouracil—skin cancer	0.00355	0.00355	CcSEcCtD
Orciprenaline—Palpitations—Docetaxel—skin cancer	0.00351	0.00351	CcSEcCtD
Orciprenaline—Asthenia—Temozolomide—skin cancer	0.00349	0.00349	CcSEcCtD
Orciprenaline—Loss of consciousness—Docetaxel—skin cancer	0.00349	0.00349	CcSEcCtD
Orciprenaline—Cough—Docetaxel—skin cancer	0.00346	0.00346	CcSEcCtD
Orciprenaline—Pruritus—Temozolomide—skin cancer	0.00345	0.00345	CcSEcCtD
Orciprenaline—Nausea—Bleomycin—skin cancer	0.00343	0.00343	CcSEcCtD
Orciprenaline—Hypertension—Docetaxel—skin cancer	0.00343	0.00343	CcSEcCtD
Orciprenaline—Vomiting—Dactinomycin—skin cancer	0.00342	0.00342	CcSEcCtD
Orciprenaline—Chest pain—Docetaxel—skin cancer	0.00338	0.00338	CcSEcCtD
Orciprenaline—Myalgia—Docetaxel—skin cancer	0.00338	0.00338	CcSEcCtD
Orciprenaline—Diarrhoea—Temozolomide—skin cancer	0.00333	0.00333	CcSEcCtD
Orciprenaline—Hypersensitivity—Fluorouracil—skin cancer	0.00331	0.00331	CcSEcCtD
Orciprenaline—Dry mouth—Docetaxel—skin cancer	0.0033	0.0033	CcSEcCtD
Orciprenaline—Anaphylactic shock—Docetaxel—skin cancer	0.00324	0.00324	CcSEcCtD
Orciprenaline—Oedema—Docetaxel—skin cancer	0.00324	0.00324	CcSEcCtD
Orciprenaline—Dizziness—Temozolomide—skin cancer	0.00322	0.00322	CcSEcCtD
Orciprenaline—Nausea—Dactinomycin—skin cancer	0.0032	0.0032	CcSEcCtD
Orciprenaline—Shock—Docetaxel—skin cancer	0.00319	0.00319	CcSEcCtD
Orciprenaline—Pruritus—Fluorouracil—skin cancer	0.00317	0.00317	CcSEcCtD
Orciprenaline—Tachycardia—Docetaxel—skin cancer	0.00316	0.00316	CcSEcCtD
Orciprenaline—Vomiting—Temozolomide—skin cancer	0.0031	0.0031	CcSEcCtD
Orciprenaline—Diarrhoea—Fluorouracil—skin cancer	0.00307	0.00307	CcSEcCtD
Orciprenaline—Headache—Temozolomide—skin cancer	0.00305	0.00305	CcSEcCtD
Orciprenaline—Dizziness—Fluorouracil—skin cancer	0.00297	0.00297	CcSEcCtD
Orciprenaline—Musculoskeletal discomfort—Docetaxel—skin cancer	0.00295	0.00295	CcSEcCtD
Orciprenaline—Insomnia—Docetaxel—skin cancer	0.00293	0.00293	CcSEcCtD
Orciprenaline—Nausea—Temozolomide—skin cancer	0.00289	0.00289	CcSEcCtD
Orciprenaline—Somnolence—Docetaxel—skin cancer	0.00288	0.00288	CcSEcCtD
Orciprenaline—Vomiting—Fluorouracil—skin cancer	0.00285	0.00285	CcSEcCtD
Orciprenaline—Headache—Fluorouracil—skin cancer	0.00281	0.00281	CcSEcCtD
Orciprenaline—Fatigue—Docetaxel—skin cancer	0.00279	0.00279	CcSEcCtD
Orciprenaline—Pain—Docetaxel—skin cancer	0.00277	0.00277	CcSEcCtD
Orciprenaline—Nausea—Fluorouracil—skin cancer	0.00267	0.00267	CcSEcCtD
Orciprenaline—Body temperature increased—Docetaxel—skin cancer	0.00256	0.00256	CcSEcCtD
Orciprenaline—Hypersensitivity—Docetaxel—skin cancer	0.00239	0.00239	CcSEcCtD
Orciprenaline—Asthenia—Docetaxel—skin cancer	0.00232	0.00232	CcSEcCtD
Orciprenaline—Pruritus—Docetaxel—skin cancer	0.00229	0.00229	CcSEcCtD
Orciprenaline—Diarrhoea—Docetaxel—skin cancer	0.00222	0.00222	CcSEcCtD
Orciprenaline—Dizziness—Docetaxel—skin cancer	0.00214	0.00214	CcSEcCtD
Orciprenaline—Vomiting—Docetaxel—skin cancer	0.00206	0.00206	CcSEcCtD
Orciprenaline—Headache—Docetaxel—skin cancer	0.00203	0.00203	CcSEcCtD
Orciprenaline—Nausea—Docetaxel—skin cancer	0.00192	0.00192	CcSEcCtD
